ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BQE Bioquell

597.00
0.00 (0.00%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioquell LSE:BQE London Ordinary Share GB0004992003 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 597.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Bioquell Share Discussion Threads

Showing 1151 to 1175 of 1500 messages
Chat Pages: Latest  48  47  46  45  44  43  42  41  40  39  38  37  Older
DateSubjectAuthorDiscuss
13/4/2016
13:31
...couldn't agree more, in the meantime heading for 180 while we await further news?
bountyhunter
13/4/2016
09:33
PA,

Totally agree, that's why I've stayed. It has always looked as though there was more than one interested party and a bid over £2 also looked likely. I have twice traded these on updates by Simon Thompson and have also considered taking my profit and reinvesting via NAS, the largest shareholder, although this would of course be on a diluted basis.

strathroyal
13/4/2016
08:43
Strathroyal, I think that most here would agree with you but my start date for this has been November with the appointment of the new broker/advisor.
Even so it has taken a long time and a number of reasons for this have been put forward, warrants/ guarantees from the previous sale to defence contracts to be transferred but the fact remains it has taken a bit of time.

On a positive note there could be more than one bidder and the company could be playing hardball and screwing the last pennny from the deal.

The facts and figures do stack up well though.
112p /share cash,an additional 30p in stock,property and equipment and a remaining business with a turnover of £27m and a gross profit of over £11m.
I see over £2/share in a takeover without much bother but a return of cash and BQE continuing in its present state wouldn't upset me too much.
I certainly see basic,hard value here.

pavey ark
13/4/2016
08:19
I never realised that such takeover negotiations could take so long. The wording suggests that an offer will be made so I'm staying invested but I had hoped this might be the investment of a lifetime not a lifetime's investment!
strathroyal
13/4/2016
07:19
I did contact the company yesterday and pointed out that regardless of the ongoing negotiations the silence from the company was unreasonable.
Whither the company is being sold or not we as shareholders have a right to know the current trading position and we had not even been given any indication of when the result for 2015 would be published.
This recent announcement merely states the obvious as the results had to be published by the end of April but MY PERSONAL INTERPRETATION is that it also indicate quite clearly that the terms of a bid are being worked out.
I must stress however that the person I spoke to at the company was very nice but very professional and gave no information to me that should not have been given out.

pavey ark
07/4/2016
18:50
When Trac was sold there were warranties put in place for a year apparently
Hence not being able to sell the co till the year was up

pinkie
07/4/2016
17:41
did someone say breakout :-)
...next stop 180? ...maybe more if we get positive news

bountyhunter
05/4/2016
16:25
No date set for figs as yet. Normally delays are bad news but suspect that some interesting news is in the offing which has complicated the picture. Difficult to say whether it will be good or bad for shareholders.
sspurt
04/4/2016
20:42
I've just had a look as far back as 2009 and the results are always in the 18th/22nd March slot so it looks like something different is happening this year.

If the review had come to nothing I would expect an announcement with the results and the results to be in the usual date slot.

I am willing to bet that some development has taken place but the big question is whither it is an outright sale or a merger.

A merger with a larger company should result in cash return to existing BQE shareholders but not the takeout bonus that most expect.

A sale would,in my opinion,result in a premium (substantial ?)to the current share price as I always felt that ST in the Investors Chronicle was undervaluing the remaining business but only time will tell and I suspect that time is close.

pavey ark
01/4/2016
12:06
Hellooo....looks as though we are breaking out
sspurt
17/3/2016
09:14
tft, good point about the comments made by the company and it certainly looks like moves are afoot.

I bought a reasonable number in August at 140p and at the time I calculated the very tangible assets to be over 140p/share (vast percentage cash but also property and stock ( stock was a very small percentage of turnover but still worth £5m at cost and that was before a 42% mark up))

The only real downside for me would be a merger with a larger company which would still fit in with the recent statements from the company but not give the quick lift in price we are probably expecting.

Even a merger should produce a cash return to BQE shareholders (£1/share ?).

Not much possible downside with very reasonable 20-30% upside,from here, does look like a good bet.

pavey ark
16/3/2016
13:42
For me, the break-out has already happened above the band of 150p to 154p.

News is due 'in and around end of Q1' so that means within a few weeks.

My analysis values an ongoing situation as c.140p to 150p,
but that a bidder could easily justify up to 222p!
so you pays your money and your takes your chance!

to me the odds are highly in favour of a bid - why?
1 - a bidder could eliminate a large element of costs from BQE thus afford to pay a higher price than the market of a small PLC
2 - BQE have said that shareholders what capital but that is expensive - so a strategic review has taken 10mths. Shareholder must be happy with progress or the board will be under pressure
3 - the talks are still on-ongoing.. so this means a deal is on. if there was disagreement about price or conditions it would have happened before now
4 - they gave a time table! I think this is very telling.
if they were in negotiations they cannot tell if the bidder would walk away tomorrow or in 2 months time. so how can they give a timetable? To me its because there are regulations / approvals to be gained (they do work in some defence sectors!!) and these were 'predictably' going to take c.2 months. Thus they could say in Jan.. we will be done 'in or around end of Q1'
5 - price action of buyers has been positive for months end during the severe market volatility during February.

So to me reading between the lines a bid for the company is more likely at anything from 180p to 222p. if there is no bid and its CASh return time the price might fall back to 140p but surely is worth 150p. So I see 10p downside on a 10%-20%.

All IMHO, DYOR + BoL
BQE is in my top5 hldgs

thirty fifty twenty
16/3/2016
13:22
Still ticking up!
nashwan123
16/3/2016
08:08
160p seems to represent a significant breakout level.
18bt
16/3/2016
00:04
Small tick up past 2 days. BQE are due to publish their biocontaination business review before the end of this month. Hopefully this will release significant shareholder value. A sale is not ruled out!
nashwan123
05/2/2016
21:01
I've updated the header charts to include volumes which may be worth keeping an eye on after today's spike.
bountyhunter
05/2/2016
18:07
nice step up today! :-)
bountyhunter
05/2/2016
09:25
I'm afraid Simon Thompson's latest update doesn't,in my opinion, give a clear picture of the current situation.
Figures are thrown about but all an investor need do is spend a little time with a calculator and the last set of results.
Stripping out all intangibles we have a very sold net asset value of c. 138p/share (112p cash, inventory, property and equipment).
The remaining business generated over £11m gross profit and ST is predicting double digit growth this year.
The £11m gross is then decimated with sales costs, reorganisation costs, board expenses etc.
ANY acquiring company will slash these cost simply because they will have a board,sales team, etc.

ST mentions £4m cash generated this year but no details.
Whatever money QUE can make it is almost certain that a larger company could make more.

No deal and they return £1 or so a share and possible merge with another company....OK by me.
If they sell the company I would expect the price to be over £2 (perhaps a good bit over £2 but I've always been a greedy sod)

pavey ark
05/2/2016
08:28
Anyone know if the pods can be used for Zika?
bakunin
05/2/2016
08:07
IC Bargain shares pick
eezymunny
05/2/2016
08:05
Something leaked?
expletive deleted
02/2/2016
20:55
Still deadly quiet here but things stirring on the share price front.
I can see why people are taking a position as it's not as though one could wait for the announcement of a sale as the MMs would have the price up before anyone could trade.
The beauty of this situation is that the downside is so limited but I think there is potential whatever happens.
If the sale of the rest of the business goes ahead the price could go up by 30 to 50% but if they announce no sale and a return of cash I think the price could drop and as I think the biotech business is a very good one there could be a chance to snap up some shares on the cheap,take the returned cash and watch the price rise when the dust settles.

pavey ark
07/1/2016
09:46
Very quiet here and absolutely no movement in the share price which suited me as I've been adding.
Looking back I see that there has been an announcement in the third week of January for the last few years and as the November update was skipped I expect news soon.
In a mild dispute with IC over my subscription but looks like it has been sorted out (not my mistake)and I should be back on with access soon.
As a result of the above I don't know if Simon Thompson has commented on BQE recently but the broker he spoke to before (now the BQE house broker and adviser !!)did say that she expected news in this January update.
I've said in previous posts I expect the remainder of the business to be sold and the takeout price to be very close to £2.
If no sale I expect £1 returned and happy to hold the remaining company but I suspect that if I'm happy to hold what looks like a nice little business then it will be sold.

pavey ark
11/12/2015
17:16
pavey ark.that will be very nice.i also bt his other tip ensor for which I will have to be more patient.
manrobert
11/12/2015
16:23
Manrobert, it does seem strange setting up a pension fund for a two year old but such is life.
I hold a fair few of these and once again I am staggered by the average AIM investor's ability to look a gift horse in the mouth.
Simon Thompson in IC did spell it all out but even he is now saying that he may have understated the case for BQE.
Hospital super bugs, growing resistance to antibiotics ,and last but by no means least, the growing terror threat and the potential for biological terror attacks, make Bioquell a very acceptable bolt on for any number of companies.

My target for a take out price is over £2 and a deal to be done by the end of January.
Higher figures have been thrown about but c. £2 will do me.

pavey ark
Chat Pages: Latest  48  47  46  45  44  43  42  41  40  39  38  37  Older

Your Recent History

Delayed Upgrade Clock